Aleva Neurotherapeutics | News

OUR NEWS

NEWS Aleva discusses first Patient experiences with PMCF principal investigators in Germany in a webinar

Aleva Recruits First Patient into PMCF Study with directSTIM Directional Deep Brain Stimulation System

Aleva receives CE Mark for its directSTIM™ Deep Brain Stimulation System

Aleva and Dixi Medical form Joint Venture to develop next generation surgical methods for the treatment of drug resistant Epilepsy

Aleva Neurotherapeutics SA and Greatbatch Inc announce collaboration for next generation Deep Brain Stimulation System (DBS).

The Michael J. Fox Foundation for Parkinson’s Research, a prestigious association dedicated to finding a cure for Parkinson's disease and funding the development of improved therapies, has awarded Aleva Neurotherapeutics SA with a research grant to support the clinical validation of our Directional DBS System.

BRAIN Publication Demonstrates Significantly Improved Therapeutic Window Using directSTIM™ Directional Electrode (May 28, 2014 http://doi.org/10.1093/brain/awu102).

Aleva Neurotherapeutics SA demonstrates Clinical Effectiveness Through Directional Deep Brain Stimulation with directSTIM™